Results 171 to 180 of about 3,959 (209)

Gingival sequestration of nifedipine in nifedipine-induced gingival overgrowth

The Lancet, 1992
The mechanism of gingival overgrowth associated with long-term use of nifedipine and of other drugs that affect calcium homoeostasis, such as cyclosporin and phenytoin, is unknown. With an ultrasensitive assay, we measured the pharmacokinetics of nifedipine in plasma and gingival crevicular fluid (GCF) of nine patients receiving this drug for angina ...
J S, Ellis, R A, Seymour, S C, Monkman, J R, Idle   +3 more
openaire   +2 more sources

Gingival overgrowth induced by cyclosporin A in rats

Archives of Oral Biology, 1990
Gingival overgrowth, which is one of the major side-effects of this immunosuppressive agent, was studied in specific pathogen-free Fischer rats fed diet No. 2000 containing 56% sucrose. Marked macroscopic overgrowth was noted in mandibular gingiva of all the rats fed this diet containing cyclosporin A.
K, Kitamura, I, Morisaki, C, Adachi, K, Kato, J, Mihara, S, Sobue, S, Hamada   +6 more
openaire   +2 more sources

Nitrendipine–Induced Gingival Overgrowth in Dogs

Journal of Periodontology, 1989
This study assessed the development of gingival overgrowth in dogs given nitrendipine, a new antihypertensive dihydropyridine. Nine male Beagle dogs with established plaque and gingivitis were used. Following a baseline examination, which involved assessment of plaque, gingivitis, and gingival enlargement, six dogs (test) received nitrendipine twice ...
L, Heijl, Y, Sundin
openaire   +2 more sources

Cyclosporin‐induced gingival overgrowth in children

International Journal of Paediatric Dentistry, 2005
SummaryCyclosporin is a potent immunosuppressant drug commonly used to prevent organ transplant rejection. In recent years, there has been a widening of its therapeutic use and an increase in the number of patients undergoing transplantation. Gingival overgrowth is one of several oral side‐effects of cyclosporin, with a quoted prevalence of between 8 ...
G, Wright, R R, Welbury, M T, Hosey
openaire   +2 more sources

Iatrogenic Gingival Overgrowth in Cardiac Transplantation

Journal of Periodontology, 1995
It is well established that both cyclosporin and nifedipine are associated with gingival overgrowth. Although both drugs are widely used in the management of organ transplant patients, there is little information on the prevalence and severity of this unwanted effect in cardiac transplant patients. This study evaluated the gingival health of 94 dentate
J M, Thomason, R A, Seymour, J S, Ellis, P J, Kelly, G, Parry, J, Dark, J R, Idle   +6 more
openaire   +2 more sources

Gingival overgrowth

2012
2, 19, Journal of Medicine and Health ...
openaire   +1 more source

The management of drug‐induced gingival overgrowth

Journal of Clinical Periodontology, 2006
AbstractObjectives: This review critically evaluates the different therapies that are available to manage drug‐induced overgrowth (DIGO).Material and Methods: This review is based on literature identified using the online databases MEDLINE and PUB MED.
M, Mavrogiannis, J S, Ellis, J M, Thomason, R A, Seymour   +3 more
openaire   +2 more sources

A clinical review of drug‐induced gingival overgrowths

Australian Dental Journal, 1999
AbstractThere is an increasing number of medications associated with gingival overgrowth. These medications are used to treat a number of common conditions in the Australian population and as such denitsts can expect to manage a number of patients with medication‐related gingival overgrowth.
Marshall, R. I., Bartold, P. M.
openaire   +5 more sources

[The causes of gingival overgrowth].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2000
Gingival overgrowth includes a series of diseases with many clinical appearances. The pathological mechanisms being obscure there were used many terms for defining it. Thus, "gingival hyperplasia" and "gingival hypertrophy" were the definitions used to define this pathology.
M, Costuleanu, P, Plămădeală, N, Costuleanu, L, Foia, A, Indrei   +4 more
openaire   +1 more source

Gingival Overgrowth in Pompe Disease: A Case Report

Journal of Oral and Maxillofacial Surgery, 2011
Pompe disease, or glycogen storage disease type 2, is a rare inheritable metabolic disease caused by a deficiency of the lysosomal enzyme acid α-glucosidase. Patients with the classic infantile form of Pompe disease present with symptoms during the first 3 months after birth, and most will die within their first year.
de Gijt, J. Pieter, van Capelle, Carine I., Oosterhuis, J. Wolter, van der Ploeg, Ans T., van der Wal, Karel G.H.   +4 more
openaire   +2 more sources